A 74-year-old, previously healthy woman was admitted with dropped head and proximal dominant limb weakness of 10 months duration ([Picture 1A](#g001){ref-type="fig"}). Laboratory testing revealed a normal creatine kinase level, euthyroid, normokalemia, a negative result for anti-human immunodeficiency virus antibody without inflammatory findings or M-protein. Electromyography showed myogenic motor unit potentials. A muscle biopsy in the biceps brachii with hematoxylin-eosin and modified Gomori-trichrome staining demonstrated a variation in the muscle fiber diameter with remarkable macrophagic infiltration in the perimysium ([Picture 2A](#g002){ref-type="fig"}), suggesting an inflammatory process, and scattered fibers with nemaline rods ([Picture 2B](#g002){ref-type="fig"}, arrows), respectively. Sporadic late-onset nemaline myopathy (SLONM) was thus diagnosed. Intravenous methylprednisolone (1,000 mg/day for 3 consecutive days ×2) was administered, resulting in a dramatic improvement in the proximal muscle weakness and the symptoms of dropped head, after 3 weeks ([Picture 1B](#g001){ref-type="fig"}). Dropped head has been reported in association with various neurological diseases, such as neuromuscular, muscular, parkinsonism and motor neuron diseases ([@B1]). SLONM should therefore be included in the differential diagnosis when encountering patients with dropped head syndrome ([@B2]).
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